• President Zelenskyy will attend the 2026 UN General Assembly to discuss the ongoing conflict in Ukraine. • President Putin is not expected to attend the event. • Zelenskyy intends to use the gathering to combat war fatigue, particularly among developing countries.
fdd.org• The FDA is expected to review several groundbreaking neurology drugs in 2026, focusing on expanding treatment options for various neurologic conditions. • A key anticipated decision involves the subcutaneous weekly dosing of lecanemab for Alzheimer's disease, which would allow for home administration. • This shift in delivery method matters as it could significantly improve patient adherence and provide greater flexibility compared to current clinic-based infusions.
neurologylive.com